世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
ヘパリン原薬 - 世界市場シェアとランキング、全体売上高と需要予測 2024-2030Heparin Active Pharmaceutical Ingredients - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 ヘパリン原薬の世界市場は2023年に17.8億米ドルと推定され、予測期間2024-2030年のCAGRは7.79%で、2030年には28.8億米ドルの再調整規模になると予測されている。 ヘパリン原薬の北米市場は、2023年に5億8,213万... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーヘパリン原薬の世界市場は2023年に17.8億米ドルと推定され、予測期間2024-2030年のCAGRは7.79%で、2030年には28.8億米ドルの再調整規模になると予測されている。ヘパリン原薬の北米市場は、2023年に5億8,213万ドルと評価され、2024年から2030年の予測期間中に7.61％のCAGRで、2030年までに9億2,308万ドルに達すると予測される。 ヘパリン原薬のアジア太平洋市場は、2023年に5億6254万ドルと評価され、2024年から2030年の予測期間中に8.83％のCAGRで、2030年までに9億7217万ドルに達するだろう。 ヘパリン原薬のヨーロッパ市場は、2023年に6億1,131万ドルと評価され、2024年から2030年の予測期間中に7.04％のCAGRで、2030年までに9億5,268万ドルに達するだろう。 ヘパリン原薬の世界的な主要企業には、深センHepalink製薬、煙台東城製薬、南京金福生物化学製薬、ファイザー、河北長山生物化学製薬、バイオベリカ、青島九龍生物製薬、常州銭鴻生物製薬、東営天東製薬などが含まれる。2023年には、世界の大手5社が売上高で約54.92％のシェアを占めている。 本レポートは、ヘパリン原薬の世界市場を包括的に提示することを目的とし、地域別・国別、タイプ別、用途別の分析とともに、総販売量、販売収益、価格、主要企業の市場シェアとランキングに焦点を当てています。 ヘパリン原薬の市場規模、推計、予測は、2023年を基準年として、2019年から2030年までの期間の履歴データと予測データとともに、販売量（億単位）と販売収入（百万ドル）で提供されます。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場での地位を分析し、ヘパリン原薬に関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。 市場区分 企業別 深圳ヘパリンク製薬 煙台東城製薬 ファイザー バイオベリカ 常州前紅生物製薬 南京キングフレンド生化学製薬 河北長山生化学製薬 青島九龍生物製薬 オポクリン 東営天東製薬 アスペン・オス 怡野製薬 南京新白薬業 湖北榎莱生物製薬 シセン製薬 タイプ別セグメント ヘパリンナトリウム ヘパリンカルシウム 用途別セグメント LMWH UFH 地域別 北米 米国 カナダ アジア太平洋 中国 日本 インド その他 欧州 ドイツ フランス 英国 イタリア スペイン その他のヨーロッパ ラテンアメリカ メキシコ ブラジル その他 中東・アフリカ 中東 アフリカ 章の概要 第1章： レポートの対象範囲、世界の総市場規模（バルブ、数量、価格）を紹介します。また、市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章：ヘパリン原薬メーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析します。 第3章：タイプ別に様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性を網羅し、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのを助ける。 第4章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのに役立ちます。 第5章：地域レベルでのヘパリン原薬の売上高、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場空間、市場規模を紹介する。 第6章 ヘパリン原薬の国別売上高、収益。各国/地域のタイプ別、用途別のシグメイトデータを提供。 第7章：主要企業のプロファイルを提供し、製品の売上高、収益、価格、売上総利益率、製品紹介など、市場の主要企業の基本的な状況を詳細に紹介します。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview 11.1 Heparin Active Pharmaceutical Ingredients Product Introduction 1 1.2 Global Heparin Active Pharmaceutical Ingredients Market Size Forecast 1 1.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Value (2019-2030) 2 1.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume (2019-2030) 4 1.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Price (2019-2030) 5 1.3 Heparin Active Pharmaceutical Ingredients Market Trends & Drivers 5 1.3.1 Heparin Active Pharmaceutical Ingredients Industry Trends 5 1.3.2 Heparin Active Pharmaceutical Ingredients Market Drivers & Opportunity 7 1.3.3 Heparin Active Pharmaceutical Ingredients Market Challenges 8 1.3.4 Heparin Active Pharmaceutical Ingredients Market Restraints 9 1.4 Assumptions and Limitations 9 1.5 Study Objectives 10 1.6 Years Considered 11 2 Competitive Analysis by Company 12 2.1 Global Heparin Active Pharmaceutical Ingredients Players Revenue Ranking (2023) 12 2.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Company (2019-2024) 13 2.3 Global Heparin Active Pharmaceutical Ingredients Players Sales Volume Ranking (2023) 15 2.4 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Company Players (2019-2024) 17 2.5 Global Heparin Active Pharmaceutical Ingredients Average Price by Company (2019-2024) 19 2.6 Key Manufacturers Heparin Active Pharmaceutical Ingredients Manufacturing Base and Headquarters 20 2.7 Key Manufacturers Heparin Active Pharmaceutical Ingredients Product Offered 21 2.8 Key Manufacturers Time to Begin Mass Production of Heparin Active Pharmaceutical Ingredients 22 2.9 Heparin Active Pharmaceutical Ingredients Market Competitive Analysis 23 2.9.1 Heparin Active Pharmaceutical Ingredients Market Concentration Rate (2019-2024) 23 2.9.2 Global 5 and 10 Largest Manufacturers by Heparin Active Pharmaceutical Ingredients Revenue in 2023 24 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Active Pharmaceutical Ingredients as of 2023) 24 2.10 Mergers & Acquisitions, Expansion 26 3 Segmentation by Type 28 3.1 Introduction by Type 28 3.1.1 Heparin Sodium 28 3.1.2 Heparin Calcium 28 3.2 Global Heparin Active Pharmaceutical Ingredients Sales Value by Type 29 3.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Type (2019 VS 2023 VS 2030) 29 3.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Type (2019-2030) 30 3.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Type (%) (2019-2030) 31 3.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Type 32 3.3.1 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Type (2019 VS 2023 VS 2030) 32 3.3.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Type (2019-2030) 33 3.3.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Type (%) (2019-2030) 33 3.4 Global Heparin Active Pharmaceutical Ingredients Average Price by Type (2019-2030) 34 4 Segmentation by Application 35 4.1 Introduction by Application 35 4.1.1 UFH 35 4.1.2 LMWH 36 4.2 Global Heparin Active Pharmaceutical Ingredients Sales Value by Application 36 4.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Application (2019 VS 2023 VS 2030) 37 4.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Application (2019-2030) 38 4.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Application (%) (2019-2030) 38 4.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Application 39 4.3.1 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Application (2019 VS 2023 VS 2030) 39 4.3.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Application (2019-2030) 40 4.3.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Application (%) (2019-2030) 41 4.4 Global Heparin Active Pharmaceutical Ingredients Average Price by Application (2019-2030) 42 5 Segmentation by Region 43 5.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region 43 5.1.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region: 2019 VS 2023 VS 2030 43 5.1.2 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (2019-2024) 43 5.1.3 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (2025-2030) 44 5.1.4 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (%), (2019-2030) 45 5.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region 46 5.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region: 2019 VS 2023 VS 2030 46 5.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (2019-2024) 46 5.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (2025-2030) 47 5.2.4 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (%), (2019-2030) 47 5.3 Global Heparin Active Pharmaceutical Ingredients Average Price by Region (2019-2030) 48 5.4 North America 49 5.4.1 North America Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 49 5.4.2 North America Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030 50 5.5 Europe 51 5.5.1 Europe Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 51 5.5.2 Europe Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030 52 5.6 Asia Pacific 53 5.6.1 Asia Pacific Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 53 5.6.2 Asia Pacific Heparin Active Pharmaceutical Ingredients Sales Value by Region (%), 2023 VS 2030 54 5.7 Latin America 55 5.7.1 Latin America Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 55 5.7.2 Latin America Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030 56 5.8 Middle East & Africa 57 5.8.1 Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 57 5.8.2 Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030 58 6 Segmentation by Key Countries/Regions 59 6.1 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value Growth Trends, 2019 VS 2023 VS 2030 59 6.2 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value 60 6.2.1 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 60 6.2.2 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Volume, 2019-2030 62 6.3 United States 65 6.3.1 United States Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 65 6.3.2 United States Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030 66 6.3.3 United States Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030 67 6.4 Europe 68 6.4.1 Europe Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 68 6.4.2 Europe Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030 69 6.4.3 Europe Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030 70 6.5 China 71 6.5.1 China Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 71 6.5.2 China Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030 72 6.5.3 China Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030 73 6.6 Japan 74 6.6.1 Japan Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 74 6.6.2 Japan Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030 75 6.6.3 Japan Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030 76 6.7 India 77 6.7.1 India Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 77 6.7.2 India Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030 78 6.7.3 India Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030 79 7 Company Profiled 80 7.1 Shenzhen Hepalink Pharmaceutical 80 7.1.1 Shenzhen Hepalink Pharmaceutical Corporation Information 80 7.1.2 Shenzhen Hepalink Pharmaceutical Introduction and Business Overview 81 7.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 81 7.1.4 Shenzhen Hepalink Pharmaceutical Heparin Products Offered 82 7.2 Yantai Dongcheng Pharmaceutical 83 7.2.1 Yantai Dongcheng Pharmaceutical Corporation Information 83 7.2.2 Yantai Dongcheng Pharmaceutical Introduction and Business Overview 84 7.2.3 Yantai Dongcheng Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 84 7.2.4 Yantai Dongcheng Pharmaceutical Heparin Products Offered 85 7.3 Pfizer 86 7.3.1 Pfizer Corporation Information 86 7.3.2 Pfizer Introduction and Business Overview 87 7.3.3 Pfizer Heparin Sales, Revenue and Gross Margin (2019-2024) 87 7.3.4 Pfizer Heparin Products Offered 88 7.4 Bioib茅rica 88 7.4.1 Bioib茅rica Corporation Information 88 7.4.2 Bioib茅rica Introduction and Business Overview 89 7.4.3 Bioib茅rica Heparin Sales, Revenue and Gross Margin (2019-2024) 90 7.4.4 Bioib茅rica Heparin Products Offered 90 7.5 Changzhou Qianhong Biopharma 92 7.5.1 Changzhou Qianhong Biopharma Corporation Information 92 7.5.2 Changzhou Qianhong Biopharma Introduction and Business Overview 93 7.5.3 Changzhou Qianhong Biopharma Heparin Sales, Revenue and Gross Margin (2019-2024) 93 7.5.4 Changzhou Qianhong Biopharma Heparin Products Offered 94 7.6 Nanjing King-friend Biochemical Pharmaceutical 95 7.6.1 Nanjing King-friend Biochemical Pharmaceutical Corporation Information 95 7.6.2 Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview 96 7.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 96 7.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Products Offered 97 7.7 Hebei Changshan Biochemical Pharmaceutical 98 7.7.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information 98 7.7.2 Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview 98 7.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 99 7.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Products Offered 99 7.8 Qingdao Jiulong Biopharmaceutical 102 7.8.1 Qingdao Jiulong Biopharmaceutical Corporation Information 102 7.8.2 Qingdao Jiulong Biopharmaceutical Introduction and Business Overview 102 7.8.3 Qingdao Jiulong Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 103 7.8.4 Qingdao Jiulong Biopharmaceutical Heparin Products Offered 104 7.9 Opocrin 105 7.9.1 Opocrin Corporation Information 105 7.9.2 Opocrin Introduction and Business Overview 106 7.9.3 Opocrin Heparin Sales, Revenue and Gross Margin (2019-2024) 106 7.9.4 Opocrin Heparin Products Offered 107 7.10 Dongying Tiandong Pharmaceutical 107 7.10.1 Dongying Tiandong Pharmaceutical Corporation Information 107 7.10.2 Dongying Tiandong Pharmaceutical Introduction and Business Overview 109 7.10.3 Dongying Tiandong Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 110 7.10.4 Dongying Tiandong Pharmaceutical Heparin Products Offered 110 7.11 Aspen Oss 111 7.11.1 Aspen Oss Corporation Information 111 7.11.2 Aspen Oss Introduction and Business Overview 112 7.11.3 Aspen Oss Heparin Sales, Revenue and Gross Margin (2019-2024) 113 7.11.4 Aspen Oss Heparin Products Offered 113 7.12 Yino Pharma 114 7.12.1 Yino Pharma Corporation Information 114 7.12.2 Yino Pharma Introduction and Business Overview 114 7.12.3 Yino Pharma Heparin Sales, Revenue and Gross Margin (2019-2024) 115 7.12.4 Yino Pharma Heparin Products Offered 115 7.13 Nanjing Xinbai Pharmaceutical 115 7.13.1 Nanjing Xinbai Pharmaceutical Corporation Information 115 7.13.2 Nanjing Xinbai Pharmaceutical Introduction and Business Overview 116 7.13.3 Nanjing Xinbai Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 117 7.13.4 Nanjing Xinbai Pharmaceutical Heparin Products Offered 117 7.14 Hubei Enoray Biopharmaceutical 118 7.14.1 Hubei Enoray Biopharmaceutical Corporation Information 118 7.14.2 Hubei Enoray Biopharmaceutical Introduction and Business Overview 119 7.14.3 Hubei Enoray Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 119 7.14.4 Hubei Enoray Biopharmaceutical Heparin Products Offered 120 7.15 Cisen Pharmaceutical 120 7.15.1 Cisen Pharmaceutical Corporation Information 120 7.15.2 Cisen Pharmaceutical Introduction and Business Overview 121 7.15.3 Cisen Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 122 7.15.4 Cisen Pharmaceutical Heparin Products Offered 122 8 Industry Chain Analysis 124 8.1 Heparin Active Pharmaceutical Ingredients Industrial Chain 124 8.2 Heparin Active Pharmaceutical Ingredients Upstream Analysis 125 8.2.1 Key Raw Materials 125 8.2.2 Raw Materials Key Suppliers 127 8.2.3 Manufacturing Cost Structure 128 8.3 Midstream Analysis 129 8.4 Downstream Analysis (Customers Analysis) 129 8.5 Sales Model and Sales Channels 131 8.5.1 Heparin Active Pharmaceutical Ingredients Sales Model 131 8.5.2 Heparin Active Pharmaceutical Ingredients Distributors 132 9 Research Findings and Conclusion 133 10 Appendix 135 10.1 Research Methodology 135 10.1.1 Methodology/Research Approach 135 10.1.2 Data Source 138 10.2 Author Details 141 10.3 Disclaimer 142
SummaryThe global market for Heparin Active Pharmaceutical Ingredients was estimated to be worth US$ 1.78 billion in 2023 and is forecast to a readjusted size of US$ 2.88 billion by 2030 with a CAGR of 7.79% during the forecast period 2024-2030. Table of Contents1 Market Overview 11.1 Heparin Active Pharmaceutical Ingredients Product Introduction 1 1.2 Global Heparin Active Pharmaceutical Ingredients Market Size Forecast 1 1.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Value (2019-2030) 2 1.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume (2019-2030) 4 1.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Price (2019-2030) 5 1.3 Heparin Active Pharmaceutical Ingredients Market Trends & Drivers 5 1.3.1 Heparin Active Pharmaceutical Ingredients Industry Trends 5 1.3.2 Heparin Active Pharmaceutical Ingredients Market Drivers & Opportunity 7 1.3.3 Heparin Active Pharmaceutical Ingredients Market Challenges 8 1.3.4 Heparin Active Pharmaceutical Ingredients Market Restraints 9 1.4 Assumptions and Limitations 9 1.5 Study Objectives 10 1.6 Years Considered 11 2 Competitive Analysis by Company 12 2.1 Global Heparin Active Pharmaceutical Ingredients Players Revenue Ranking (2023) 12 2.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Company (2019-2024) 13 2.3 Global Heparin Active Pharmaceutical Ingredients Players Sales Volume Ranking (2023) 15 2.4 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Company Players (2019-2024) 17 2.5 Global Heparin Active Pharmaceutical Ingredients Average Price by Company (2019-2024) 19 2.6 Key Manufacturers Heparin Active Pharmaceutical Ingredients Manufacturing Base and Headquarters 20 2.7 Key Manufacturers Heparin Active Pharmaceutical Ingredients Product Offered 21 2.8 Key Manufacturers Time to Begin Mass Production of Heparin Active Pharmaceutical Ingredients 22 2.9 Heparin Active Pharmaceutical Ingredients Market Competitive Analysis 23 2.9.1 Heparin Active Pharmaceutical Ingredients Market Concentration Rate (2019-2024) 23 2.9.2 Global 5 and 10 Largest Manufacturers by Heparin Active Pharmaceutical Ingredients Revenue in 2023 24 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Active Pharmaceutical Ingredients as of 2023) 24 2.10 Mergers & Acquisitions, Expansion 26 3 Segmentation by Type 28 3.1 Introduction by Type 28 3.1.1 Heparin Sodium 28 3.1.2 Heparin Calcium 28 3.2 Global Heparin Active Pharmaceutical Ingredients Sales Value by Type 29 3.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Type (2019 VS 2023 VS 2030) 29 3.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Type (2019-2030) 30 3.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Type (%) (2019-2030) 31 3.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Type 32 3.3.1 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Type (2019 VS 2023 VS 2030) 32 3.3.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Type (2019-2030) 33 3.3.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Type (%) (2019-2030) 33 3.4 Global Heparin Active Pharmaceutical Ingredients Average Price by Type (2019-2030) 34 4 Segmentation by Application 35 4.1 Introduction by Application 35 4.1.1 UFH 35 4.1.2 LMWH 36 4.2 Global Heparin Active Pharmaceutical Ingredients Sales Value by Application 36 4.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Application (2019 VS 2023 VS 2030) 37 4.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Application (2019-2030) 38 4.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Value, by Application (%) (2019-2030) 38 4.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Application 39 4.3.1 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Application (2019 VS 2023 VS 2030) 39 4.3.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Application (2019-2030) 40 4.3.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume, by Application (%) (2019-2030) 41 4.4 Global Heparin Active Pharmaceutical Ingredients Average Price by Application (2019-2030) 42 5 Segmentation by Region 43 5.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region 43 5.1.1 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region: 2019 VS 2023 VS 2030 43 5.1.2 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (2019-2024) 43 5.1.3 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (2025-2030) 44 5.1.4 Global Heparin Active Pharmaceutical Ingredients Sales Value by Region (%), (2019-2030) 45 5.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region 46 5.2.1 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region: 2019 VS 2023 VS 2030 46 5.2.2 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (2019-2024) 46 5.2.3 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (2025-2030) 47 5.2.4 Global Heparin Active Pharmaceutical Ingredients Sales Volume by Region (%), (2019-2030) 47 5.3 Global Heparin Active Pharmaceutical Ingredients Average Price by Region (2019-2030) 48 5.4 North America 49 5.4.1 North America Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 49 5.4.2 North America Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030 50 5.5 Europe 51 5.5.1 Europe Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 51 5.5.2 Europe Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030 52 5.6 Asia Pacific 53 5.6.1 Asia Pacific Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 53 5.6.2 Asia Pacific Heparin Active Pharmaceutical Ingredients Sales Value by Region (%), 2023 VS 2030 54 5.7 Latin America 55 5.7.1 Latin America Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 55 5.7.2 Latin America Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030 56 5.8 Middle East & Africa 57 5.8.1 Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 57 5.8.2 Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Value by Country (%), 2023 VS 2030 58 6 Segmentation by Key Countries/Regions 59 6.1 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value Growth Trends, 2019 VS 2023 VS 2030 59 6.2 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value 60 6.2.1 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 60 6.2.2 Key Countries/Regions Heparin Active Pharmaceutical Ingredients Sales Volume, 2019-2030 62 6.3 United States 65 6.3.1 United States Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 65 6.3.2 United States Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030 66 6.3.3 United States Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030 67 6.4 Europe 68 6.4.1 Europe Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 68 6.4.2 Europe Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030 69 6.4.3 Europe Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030 70 6.5 China 71 6.5.1 China Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 71 6.5.2 China Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030 72 6.5.3 China Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030 73 6.6 Japan 74 6.6.1 Japan Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 74 6.6.2 Japan Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030 75 6.6.3 Japan Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030 76 6.7 India 77 6.7.1 India Heparin Active Pharmaceutical Ingredients Sales Value, 2019-2030 77 6.7.2 India Heparin Active Pharmaceutical Ingredients Sales Value by Type (%), 2023 VS 2030 78 6.7.3 India Heparin Active Pharmaceutical Ingredients Sales Value by Application, 2023 VS 2030 79 7 Company Profiled 80 7.1 Shenzhen Hepalink Pharmaceutical 80 7.1.1 Shenzhen Hepalink Pharmaceutical Corporation Information 80 7.1.2 Shenzhen Hepalink Pharmaceutical Introduction and Business Overview 81 7.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 81 7.1.4 Shenzhen Hepalink Pharmaceutical Heparin Products Offered 82 7.2 Yantai Dongcheng Pharmaceutical 83 7.2.1 Yantai Dongcheng Pharmaceutical Corporation Information 83 7.2.2 Yantai Dongcheng Pharmaceutical Introduction and Business Overview 84 7.2.3 Yantai Dongcheng Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 84 7.2.4 Yantai Dongcheng Pharmaceutical Heparin Products Offered 85 7.3 Pfizer 86 7.3.1 Pfizer Corporation Information 86 7.3.2 Pfizer Introduction and Business Overview 87 7.3.3 Pfizer Heparin Sales, Revenue and Gross Margin (2019-2024) 87 7.3.4 Pfizer Heparin Products Offered 88 7.4 Bioib茅rica 88 7.4.1 Bioib茅rica Corporation Information 88 7.4.2 Bioib茅rica Introduction and Business Overview 89 7.4.3 Bioib茅rica Heparin Sales, Revenue and Gross Margin (2019-2024) 90 7.4.4 Bioib茅rica Heparin Products Offered 90 7.5 Changzhou Qianhong Biopharma 92 7.5.1 Changzhou Qianhong Biopharma Corporation Information 92 7.5.2 Changzhou Qianhong Biopharma Introduction and Business Overview 93 7.5.3 Changzhou Qianhong Biopharma Heparin Sales, Revenue and Gross Margin (2019-2024) 93 7.5.4 Changzhou Qianhong Biopharma Heparin Products Offered 94 7.6 Nanjing King-friend Biochemical Pharmaceutical 95 7.6.1 Nanjing King-friend Biochemical Pharmaceutical Corporation Information 95 7.6.2 Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview 96 7.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 96 7.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Products Offered 97 7.7 Hebei Changshan Biochemical Pharmaceutical 98 7.7.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information 98 7.7.2 Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview 98 7.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 99 7.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Products Offered 99 7.8 Qingdao Jiulong Biopharmaceutical 102 7.8.1 Qingdao Jiulong Biopharmaceutical Corporation Information 102 7.8.2 Qingdao Jiulong Biopharmaceutical Introduction and Business Overview 102 7.8.3 Qingdao Jiulong Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 103 7.8.4 Qingdao Jiulong Biopharmaceutical Heparin Products Offered 104 7.9 Opocrin 105 7.9.1 Opocrin Corporation Information 105 7.9.2 Opocrin Introduction and Business Overview 106 7.9.3 Opocrin Heparin Sales, Revenue and Gross Margin (2019-2024) 106 7.9.4 Opocrin Heparin Products Offered 107 7.10 Dongying Tiandong Pharmaceutical 107 7.10.1 Dongying Tiandong Pharmaceutical Corporation Information 107 7.10.2 Dongying Tiandong Pharmaceutical Introduction and Business Overview 109 7.10.3 Dongying Tiandong Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 110 7.10.4 Dongying Tiandong Pharmaceutical Heparin Products Offered 110 7.11 Aspen Oss 111 7.11.1 Aspen Oss Corporation Information 111 7.11.2 Aspen Oss Introduction and Business Overview 112 7.11.3 Aspen Oss Heparin Sales, Revenue and Gross Margin (2019-2024) 113 7.11.4 Aspen Oss Heparin Products Offered 113 7.12 Yino Pharma 114 7.12.1 Yino Pharma Corporation Information 114 7.12.2 Yino Pharma Introduction and Business Overview 114 7.12.3 Yino Pharma Heparin Sales, Revenue and Gross Margin (2019-2024) 115 7.12.4 Yino Pharma Heparin Products Offered 115 7.13 Nanjing Xinbai Pharmaceutical 115 7.13.1 Nanjing Xinbai Pharmaceutical Corporation Information 115 7.13.2 Nanjing Xinbai Pharmaceutical Introduction and Business Overview 116 7.13.3 Nanjing Xinbai Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 117 7.13.4 Nanjing Xinbai Pharmaceutical Heparin Products Offered 117 7.14 Hubei Enoray Biopharmaceutical 118 7.14.1 Hubei Enoray Biopharmaceutical Corporation Information 118 7.14.2 Hubei Enoray Biopharmaceutical Introduction and Business Overview 119 7.14.3 Hubei Enoray Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 119 7.14.4 Hubei Enoray Biopharmaceutical Heparin Products Offered 120 7.15 Cisen Pharmaceutical 120 7.15.1 Cisen Pharmaceutical Corporation Information 120 7.15.2 Cisen Pharmaceutical Introduction and Business Overview 121 7.15.3 Cisen Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024) 122 7.15.4 Cisen Pharmaceutical Heparin Products Offered 122 8 Industry Chain Analysis 124 8.1 Heparin Active Pharmaceutical Ingredients Industrial Chain 124 8.2 Heparin Active Pharmaceutical Ingredients Upstream Analysis 125 8.2.1 Key Raw Materials 125 8.2.2 Raw Materials Key Suppliers 127 8.2.3 Manufacturing Cost Structure 128 8.3 Midstream Analysis 129 8.4 Downstream Analysis (Customers Analysis) 129 8.5 Sales Model and Sales Channels 131 8.5.1 Heparin Active Pharmaceutical Ingredients Sales Model 131 8.5.2 Heparin Active Pharmaceutical Ingredients Distributors 132 9 Research Findings and Conclusion 133 10 Appendix 135 10.1 Research Methodology 135 10.1.1 Methodology/Research Approach 135 10.1.2 Data Source 138 10.2 Author Details 141 10.3 Disclaimer 142
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（ケミカル）の最新刊レポートQYResearch社の化学・材料分野での最新刊レポート
本レポートと同じKEY WORD（active pharmaceutical）の最新刊レポートよくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/20 10:28 158.95 円 165.20 円 201.28 円 |
